Both in Pharmaceuticals
Rallybio vs PDS Biotechnology
Over the past year RLYB returned +232.9% and PDSB returned +18.9%; their daily moves had a correlation of 0.07.
RLYB +232.9% PDSB +18.9%Growth of $1, one year, split-adjusted
| Metric | RLYB | PDSB |
|---|---|---|
| Price | $16.64 | $1.11 |
| Market cap | $88.4M | $80.4M |
| Today | +1.46% | −4.31% |
| 1 month | +0.2% | +38.7% |
| 6 months | +92.8% | +23.3% |
| Year to date | +203.2% | +44.2% |
| 1 year | +270.8% | +18.7% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 1.9× | — |
| Price / sales | 136.8× | — |
| Net cash | $92.8M | $1.2M |
| Dividend yield | — | — |
| Volatility (60d) | 21.5% | 311.3% |
| Short % of float | 1.9% | 5.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).